These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 27544072)

  • 61. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
    Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
    Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors.
    He H; Wang W; Zhou Y; Xia Q; Ren Y; Feng J; Peng H; He H; Feng L
    Bioorg Med Chem; 2016 Apr; 24(8):1879-88. PubMed ID: 26972920
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and docking studies of N-(5-(alkylthio)-1,3,4-oxadiazol-2-yl)methyl)benzamide analogues as potential alkaline phosphatase inhibitors.
    Iqbal Z; Iqbal A; Ashraf Z; Latif M; Hassan M; Nadeem H
    Drug Dev Res; 2019 Aug; 80(5):646-654. PubMed ID: 31032540
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hydantoin based dual inhibitors of ALR2 and PARP-1: Design, synthesis, in-vitro and in-vivo evaluation.
    Kumar M; Kumar Singh P; Choudhary S; Silakari O
    Bioorg Chem; 2022 Dec; 129():106108. PubMed ID: 36063781
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling.
    Kassem AF; Sabt A; Korycka-Machala M; Shaldam MA; Kawka M; Dziadek B; Kuzioła M; Dziadek J; Batran RZ
    Bioorg Chem; 2024 Sep; 150():107511. PubMed ID: 38870705
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
    Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
    Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acetic acid derivatives of 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide as a novel class of potent aldose reductase inhibitors.
    Chen X; Zhu C; Guo F; Qiu X; Yang Y; Zhang S; He M; Parveen S; Jing C; Li Y; Ma B
    J Med Chem; 2010 Dec; 53(23):8330-44. PubMed ID: 21062005
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S; Parveen S; Hao X; Zhang S; Wang W; Qin X; Yang Y; Chen X; Zhu S; Zhu C; Ma B
    Eur J Med Chem; 2014 Jun; 80():383-92. PubMed ID: 24793885
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of novel N-(1,3-thiazol-2-yl)benzamide clubbed oxadiazole scaffolds: Urease inhibition, Lipinski rule and molecular docking analyses.
    Athar Abbasi M; Raza H; Aziz-Ur-Rehman ; Zahra Siddiqui S; Adnan Ali Shah S; Hassan M; Seo SY
    Bioorg Chem; 2019 Mar; 83():63-75. PubMed ID: 30342387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and biological evaluation of 2'-oxo-2,3-dihydro-3'H- spiro[chromene-4,5'-[1,3]oxazolidin]-3'yl]acetic acid derivatives as aldose reductase inhibitors.
    Rapposelli S; Da Settimo F; Digiacomo M; La Motta C; Lapucci A; Sartini S; Vanni M
    Arch Pharm (Weinheim); 2011 Jun; 344(6):372-85. PubMed ID: 21319207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms.
    Vander Jagt DL; Hunsaker LA; Robinson B; Stangebye LA; Deck LM
    J Biol Chem; 1990 Jul; 265(19):10912-8. PubMed ID: 2113526
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity.
    Majekova M; Ballekova J; Prnova M; Stefek M
    Bioorg Med Chem; 2017 Dec; 25(24):6353-6360. PubMed ID: 29074349
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3H)-one derivatives as potential aldose reductase inhibitors.
    Tokalı FS; Demir Y; Demircioğlu İH; Türkeş C; Kalay E; Şendil K; Beydemir Ş
    Drug Dev Res; 2022 May; 83(3):586-604. PubMed ID: 34585414
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural bases for the inhibition of aldose reductase by phenolic compounds.
    Rastelli G; Antolini L; Benvenuti S; Costantino L
    Bioorg Med Chem; 2000 May; 8(5):1151-8. PubMed ID: 10882025
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
    Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
    Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
    Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
    Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations.
    Wang L; Gu Q; Zheng X; Ye J; Liu Z; Li J; Hu X; Hagler A; Xu J
    J Chem Inf Model; 2013 Sep; 53(9):2409-22. PubMed ID: 23901876
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives.
    Sun WS; Park YS; Yoo J; Park KD; Kim SH; Kim JH; Park HJ
    J Med Chem; 2003 Dec; 46(26):5619-27. PubMed ID: 14667216
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
    Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
    J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.